Nurse Practitioner in Wahiawa, HI Accepting Medicare

8 Nurse Practitioner nurses found. Showing 1 - 8

My Danielsson Oleary, APRN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 128 Lehua St, Wahiawa, HI 96786 Phone: 808-520-1172

Anabelen Taylor, FNP-BC.MSN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 925 California Ave, Wahiawa, HI 96786 Phone: 808-621-7772    Fax: 808-622-2040

Mrs. Kelly Michele Cerutti, ANP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 925 California Avenue, Cvs Minuteclinic #09300, Wahiawa, HI 96786 Phone: 808-621-7772

Susan Yee-loh, APRN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 960 Center St, Wahiawa, HI 96786 Phone: 808-621-6511

Cassie Ann Espresion Claveria, APRN Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 925 California Ave, Wahiawa, HI 96786 Phone: 808-621-7772

Melissa M Sutherland, APRN Nurse Practitioner - Primary Care Medicare: Accepting Medicare Assignments Practice Location: 302 California Ave Ste 106, Wahiawa, HI 96786 Phone: 808-621-8269

Kailene Oliveros, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 275 Rose St, Wahiawa, HI 96786 Phone: 808-861-6839    Fax: 808-536-7315

Monica Perpignan, Nurse Practitioner - Primary Care Medicare: Medicare Enrolled Practice Location: 634 Kilani Ave, Wahiawa, HI 96786 Phone: 808-392-8959

News Archive

Boehringer announces LUX-Lung 8 data that compares efficacy of afatinib, erlotinib in patients with advanced SCC

Boehringer Ingelheim today announced overall survival (OS) results from the LUX-Lung 8 trial (NCT01523587) that directly compared the efficacy and safety of two EGFR-directed treatments, afatinib and erlotinib, in patients with advanced squamous cell carcinoma (SCC) of the lung, progressing after treatment with first-line chemotherapy. Treatment with afatinib significantly reduced the risk of death by 19%, extending the survival of patients to a median of 7.9 months compared to 6.8 months on erlotinib.

UMF sponsors second annual Hygiene Specialist Excellence award

Environmental Services Managers are encouraged to nominate the housekeeper of their choice for the second annual Hygiene Specialist Excellence award, which is sponsored by UMF Corporation, developer of the PerfectCLEAN Infection Prevention System.

VCU receives $6 million grant to develop safe, effective treatments for cocaine addiction

Virginia Commonwealth University has received a five-year, $6 million grant for clinical research and education directed toward the identification, evaluation and development of safe and effective treatments for cocaine addiction.

Surgical treatment of morbid obesity increases likelihood of patients returning to work

Obese Medicaid patients who undergo Roux-en-Y gastric bypass surgery may be more likely to return to work than obese Medicaid patients who do not undergo the surgery, according to a report in the October issue of Archives of Surgery, a theme issue on bariatric surgery.

Read more Medical News

› Verified 2 days ago